GSK said on Friday the European Medicines Agency had accepted the drugmaker's application to expand the use of its ...

GSK PLC GSK shares dropped 2.45% to £15.12 Friday, on what proved to be an all-around poor trading session for the stock ...

GSK said on Friday the European Medicines Agency had accepted the drugmaker's application to expand the use of its ...

The debate continues over the potential of measurable residual disease to transform research and clinical care in hematology.

Robert F. Kennedy Jr. faced questions from Congress about his own potential conflicts of interest during a confirmation ...

GSK (LSE:GSK) announced that the European Medicines Agency accepted its regulatory application to expand the use of its RSV ...

The partnership includes support for the design of the Phase III trial and assistance in securing external funding.

London: GSK plc has announced that the European Medicines Agency (EMA) has accepted the company's regulatory application to ...

India also impacted by Shigellosis, a severe form of bacterial diarrhoea that disproportionately affects children under five ...

GSK has licensed its shigella vaccine candidate to Bharat Biotech. The Big Pharma, which has vowed to help Bharat with trial ...

This collaboration reflects Bharat Biotech’s continued commitment to global public health and equitable vaccine access ...

Under terms of the deal, Bharat Biotech will lead late-stage development and scale-up of the altSonflex1-2-3 Shigella vaccine ...